Gordon M. Binder, Amgen’s chief executive, was...
Gordon M. Binder, Amgen’s chief executive, was elected chairman of the Thousand Oaks biotechnology company, replacing outgoing chairman George B. Rathmann. Amgen said Rathmann, who joined the company when it was founded by a group of venture capitalists in 1980, was reelected to the board of directors and will serve as chairman emeritus.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
